ArticleActas espanolas de psiquiatria2026
Mortality Risks in Patients With Schizophrenia in Shanghai: A Longitudinal Cohort Study.
Article in Actas espanolas de psiquiatria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchizophrenia is a severe mental disorder associated with significantly higher mortality risk than the general population, constituting a major public health challenge. Clarifying temporal trends in mortality among patients with schizophrenia helps inform targeted clinical and public health interventions. To assess changes in mortality rates over the last 2 years in patients with schizophrenia from one district of Shanghai, China.
methodsThis longitudinal cohort study assessed the mortality of individuals with schizophrenia (n = 5234) from April 1, 2021, to March 31, 2023. The early cohort (up to March 31, 2022) contained 5207 individuals and the late cohort (up to March 31, 2023) contained 5114 individuals. Partitions of Pearson's chi-square statistic were used to conduct pairwise comparisons. A multivariable Cox proportional hazards model was used to assess the effects of different factors on mortality risk. Data were drawn from the official Shanghai database used for following-up individuals with severe mental health disorders.
resultsThe total number of deaths was 370. Of these, 120 occurred in the early cohort (2.30% of the cohort) and 250 in the late cohort (4.89% of the cohort). Individuals with schizophrenia in the late cohort had a 5.08- fold increased mortality risk than individuals in the general population. In the early cohort, mortality rates remained relatively stable (0.29%-0.48%). There were peaks in mortality rates (2.23%) in December 2022 and January 2023. Men had a higher risk of mortality than women (hazard ratio [HR], 1.294; 95% confidence interval [CI], 1.035-1.618; p = 0.024). Age was a contributing factor to the mortality of people with schizophrenia (HR, 1.048; 95% CI, 1.040- 1.056; p < 0.001). Being unmarried (HR, 1.956; 95% CI, 1.522-2.513; p < 0.001), divorced (HR, 1.481; 95% CI, 1.010-2.170; p = 0.044), or widowed (HR, 1.334; 95% CI, 0.958-1.856; p = 0.088) was associated with a high risk of mortality. Age of onset (HR, 1.046; 95% CI, 1.037- 1.054; p < 0.001) and illness duration (HR, 1.044; 95% CI, 1.037-1.051; p < 0.001) were associated with high mortality risk. The late cohort showed a higher mortality rate than the early cohort (HR, 2.427; 95% CI, 1.467-4.014; p = 0.001). The mortality of patients with schizophrenia was not significantly related to education level, economic status, or symptom onset.
conclusionsThese findings highlight trends in schizophrenia mortality since April 2021. Compared with the general population, individuals with schizophrenia had higher mortality risk, particularly adults aged ≥65 years and women with low education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.